About Hospital Carlos III
El Hospital Carlos III es un hospital público situado en la ciudad de Madrid perteneciente al Servicio Madrileño de Salud.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Abbott
4
Gilead Sciences
3
Hospital Carlos III, Madrid
3
ViiV Healthcare
3
AB Science
2
Bristol-Myers Squibb
2
Human Genome Sciences Inc.
2
Knopp Biosciences
2
Pfizer
2
ANRS, Emerging Infectious Diseases
1
Bausch Health Americas, Inc.
1
Clinical Trials at Hospital Carlos III
During the past decade, Hospital Carlos III conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 8 clinical trials were completed, i.e. on
average, 800% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment
Completed
300
A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy
1999-03-01
Completed
660
A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine
2001-02-01
2003-04-01
Completed
Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)
2001-02-01
2003-09-01
Completed
Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor
2001-04-01
Completed
16
Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART
2001-04-01
Completed
24
Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive
2004-06-01
2006-05-01
Completed
900
Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients
2006-12-01
2009-02-01
Completed
1,331
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital Carlos III" #1 sponsor was "Abbott" with 4 trials, followed by "Gilead Sciences" with 3 trials
sponsored, "Hospital Carlos III, Madrid" with 3 trials sponsored, "ViiV Healthcare" with 3 trials sponsored and "AB Science"
with 3 trials sponsored. Other sponsors include 10 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Carlos III"
#1 collaborator was "Novartis" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "NEAT - European AIDS Treatment Network" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Hospital Carlos III
According to Clinical.Site data, the most researched conditions in "Hospital Carlos III" are
"HIV Infections" (10 trials), "Chronic Hepatitis C" (6 trials), "Amyotrophic Lateral Sclerosis" (4 trials), "Cardiovascular Disease" (3 trials) and "ALS" (1 trials). Many other conditions were trialed in "Hospital Carlos III" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Carlos III
Most popular intervention types in "Hospital Carlos III" are "Drug" (28 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Lopinavir/Ritonavir" (3 trials), "Ribavirin" (3 trials), "Riluzole" (3 trials) and "Amprenavir/ritonavir" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Carlos III
The vast majority of trials in "Hospital Carlos III" are
30 trials for "All" genders.
Clinical Trials Status at Hospital Carlos III
Currently, there are NaN active trials in "Hospital Carlos III".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 23 completed trials in Hospital Carlos III,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Carlos III, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 18 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 6 trials, and there were
also 0 trials that are defined as “Not Applicable".